These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27891635)

  • 41. Pharmaceutical Cost Savings in the Intensive Care Unit.
    Pennell BT; Murphy CV; Byrd C; Tubbs C
    Crit Care Nurs Q; 2017; 40(4):414-423. PubMed ID: 28834862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. US drug shortages compared to the World Health Organization's Model List of Essential Medicines for Children: A cross-sectional study.
    Patel R; Samiee-Zafarghandy S; Ziesenitz V; Fox ER; Van Den Anker J; Ong H; Mazer-Amirshahi M
    Am J Health Syst Pharm; 2022 Nov; 79(22):2012-2017. PubMed ID: 35913934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ethical framework for resource allocation during a drug supply shortage.
    Gibson JL; Bean S; Chidwick P; Godkin D; Sibbald RW; Wagner F
    Healthc Q; 2012; 15(3):26-35. PubMed ID: 22986563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Price comparison of high-cost originator medicines in European countries.
    Vogler S; Zimmermann N; Babar ZU
    Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):221-230. PubMed ID: 27658050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden.
    Davidova J; Praznovcova L; Lundborg CS
    Pharm World Sci; 2008 Jan; 30(1):57-64. PubMed ID: 17588212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug shortages and patient safety: an overview of essential information for the infusion nurse.
    McLaughlin MM; Skoglund EW
    J Infus Nurs; 2015; 38(3):205-8. PubMed ID: 25871867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug shortages in European countries: a trade-off between market attractiveness and cost containment?
    Pauwels K; Huys I; Casteels M; Simoens S
    BMC Health Serv Res; 2014 Sep; 14():438. PubMed ID: 25257912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medicine shortages in Australia: causes, impact and management strategies in the community setting.
    Tan YX; Moles RJ; Chaar BB
    Int J Clin Pharm; 2016 Oct; 38(5):1133-41. PubMed ID: 27383246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Shortage of generic neurologic therapeutics: An escalating threat to patient care.
    Omorodion JO; Algahtani RM; Zocchi MS; Fox ER; Pines JM; Kaminski HJ
    Neurology; 2017 Dec; 89(24):2431-2437. PubMed ID: 29142086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New regulatory strategies to manage medicines shortages in Europe.
    Musazzi UM; Di Giorgio D; Minghetti P
    Int J Pharm; 2020 Apr; 579():119171. PubMed ID: 32092455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Persistent drug shortages jeopardise patient safety in the USA.
    Furlow B
    Lancet Respir Med; 2015 Mar; 3(3):182-3. PubMed ID: 25732929
    [No Abstract]   [Full Text] [Related]  

  • 52. [Shortages in medicinal products in a tertiary care hospital in Spain].
    González-Martín C; Saavedra-Quirós V; Ruiz-Gutiérrez J; García-Sanz E; Sánchez-Guerrero A
    Rev Calid Asist; 2017; 32(5):289-291. PubMed ID: 29017752
    [No Abstract]   [Full Text] [Related]  

  • 53. Shortages of Palliative Care Medications in Canada during the COVID-19 Pandemic: Gambling with Suffering.
    Pereira J; Arya A; Downar J; Rice P; MacDonald S; Osborne E; Kanji S; Sauls R
    Healthc Q; 2021 Jan; 23(4):17-22. PubMed ID: 33475487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of drug shortages on the pharmacy, nursing, and medical staff's ability to effectively care for critically ill patients.
    Gulbis BE; Ruiz MC; Denktas AE
    Crit Care Nurs Q; 2013; 36(4):400-6. PubMed ID: 24002429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implications of external price referencing of pharmaceuticals in Middle East countries.
    Kaló Z; Alabbadi I; Al Ahdab OG; Alowayesh M; Elmahdawy M; Al-Saggabi AH; Tanzi VL; Al-Badriyeh D; Alsultan HS; Ali FM; Elsisi GH; Akhras KS; Vokó Z; Kanavos P
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):993-8. PubMed ID: 26088919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parenteral nutrition product shortages: impact on safety.
    Holcombe B
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):44S-47S. PubMed ID: 22282871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prescription Drug Shortages: Implications for Ambulatory Pediatrics.
    Donnelly KA; Zocchi MS; Katy TA; Fox ER; van den Anker JN; Mazer-Amirshahi ME
    J Pediatr; 2018 Aug; 199():65-70. PubMed ID: 29752177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of shortages of injectable oncology drugs on patient care.
    Goldsack JC; Reilly C; Bush C; McElligott S; Bristol MN; Motanya UN; Field R; Vozniak JM; Wong YN; Schwartz JS; Domchek S
    Am J Health Syst Pharm; 2014 Apr; 71(7):571-8. PubMed ID: 24644117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A prescription for drug shortages.
    Gehrett BK
    JAMA; 2012 Jan; 307(2):153-4. PubMed ID: 22235084
    [No Abstract]   [Full Text] [Related]  

  • 60. Why drug shortages occur.
    Drug Ther Bull; 2015 Mar; 53(3):33-6. PubMed ID: 25765598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.